Lv1
60 积分 2023-01-04 加入
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
7天前
已完结
Une thrombose veineuse cérébrale révélant une hémoglobinurie paroxystique nocturne
11天前
已关闭
Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibition
1个月前
已完结
Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria
1个月前
已关闭
Modern chemistry is rubbish
2个月前
已完结
An Electrochemically Driven Oxidative Strecker Reaction via the Unique Hydroxymethyl Radical Intermediate
4个月前
已完结
ERS/EBMT clinical practice guideline on treatment of pulmonary chronic graft-versus-host disease in adults
6个月前
已完结
Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative review
10个月前
已完结
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
10个月前
已完结
Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
1年前
已完结
皖公网安备34019202002308
